1. Introduction {#sec1}
===============

Gastrectomy with D2 dissection has been a standard surgical procedure for resectable gastric cancer in the treatment guidelines of the Japanese Gastric Cancer Association (JGCA) [@bib1], [@bib2]. These recommendations are based on the large amounts of data obtained from patients who had undergone gastrectomy in Japan.

However, some studies from western countries reported that patients with gastric cancer treated by D2 dissection had a significantly higher rate of complications, a higher postoperative mortality rate and a longer hospital stay than those who had D1 dissection [@bib3]. More attention should be payed to the improvement of postoperative quality of life without impairing long term outcome. Gastrectomy with D2 seems to be an overly invasive surgery for patients with pN0 gastric cancer.

According to this background, sentinel node concept has been introduced for early gastric cancer surgery. In fact, Several successful single-institution studies for sentinel node (SN) mapping in gastric cancer have been reported [@bib4], [@bib5], [@bib6], [@bib7], [@bib8].

However, the indications and the procedures applied for SN mapping in these previous reports varied. Kitagawa et al. conducted prospective multicenter trial for sentinel node mapping using the dual tracer method with technetium 99 m--labeled tin colloid and 1% isosulfan blue dye [@bib9]. In several institutions, indocyanine green fluorescence SN mapping has been performed [@bib8], [@bib14].

Recently, PINPOINT^®^ (NOVADAQ, Canada) has developed for ICG fluorescence guided surgery [@bib10], [@bib11], [@bib12]. Evaluations of the blood supply for reconstructed organ and anastomosis in gastrointestinal surgery has been reported. In our institute, PINPOINT has been applied for gastric cancer surgery to identify lymphatic flows and SNs.

The present study describes the retrospective feasibility study of ICG fluorescence SN mapping in back-table for early gastric cancer using PINPOINT.

2. Patients and methods {#sec2}
=======================

The protocol was approved by the Ethics Committee for Biomedical Research of the International University of Health and Welfare Hospital, and all patients provided informed consent.

Nine patients diagnosed as early gastric cancer with no obvious metastasis were admitted to our hospital between September and December in 2015. In this study, six patients with cT1N0 or cT2N0 gastric cancer were enrolled and evaluated retrospectively.

Injection of the tracer was performed according to Kitagawa\'s dual tracer method [@bib4], [@bib9]. The day before surgery, ICG (ICG: Diagnogreen^®^; Dai-Ichi Sankyo Pharm, Tokyo, Japan) was injected in four quadrants of the submucosal layer of the primary lesion by using an endoscopic puncture needle ([Fig. 1](#fig1){ref-type="fig"}). As a preliminary trial, for five case each 50.0 μg/ml of the ICG was injected. During the course of this trial, quality of camera scope for ICG fluorescence imaging was fixed and improved, and the number of ICG positive lymph node increased too much. Therefore, we decrease the concentration of ICG to 33.3 μg/ml for last case.Fig. 1Injection of the tracer. The day before surgery, ICG was injected in four quadrants of the submucosal layer of the primary lesion by using an endoscopic puncture needle.Fig. 1

Intraoperatively, surgical field was made to visualize all possible directions of lymphatic flow. For ICG fluorescence imaging, PINPOINT^®^ was used and illuminated regional lymph nodes from the serosal side with three modes (Pinpoint mode, spy mode, colorized mode) ([Fig. 2](#fig2){ref-type="fig"}). Positive staining was confirmed by at least 3 surgeons during surgery.Fig. 2Intra-operative ICG fluorescence imaging with PINPOINT^®^ (Pinpoint mode, colorized mode, spy mode). This image was obtained from Case② patient.Fig. 2

Lymph node dissection and gastrectomy were performed according to the criteria of gastric cancer treatment guidelines of JGCA regardless of intraoperative SN result. Range for the node dissection and gastrectomy depended on the preoperative diagnosis of the depth and location. This is because SN biopsy has established false negative rates and has not been incorporated into standard work-up as per oncological surgery guidelines (such as NCCN).

Postoperatively, back-table observation of staining nodes and pathological examination with haematoxylin and eosin staining was performed ([Fig. 3](#fig3){ref-type="fig"}). Findings of macroscopy and pathology were described according to the Japanese classification of gastric carcinoma (3rd English edition) [@bib3].Fig. 3Postoperative back-table observation of staining nodes obtained from Case② patient.Fig. 3

Injection of the ICG and laparoscopic gastrectomy were performed by two surgeons (Hironori Ohdaira and Masashi Yoshida). Pathological examination were done by one pathologist (Shinya Okada).

3. Results {#sec3}
==========

No allergic reaction were observed after ICG injection.

All the six patients\' characteristics are listed in [Table 1](#tbl1){ref-type="table"}. All the patients had gastrectomy with laparoscopic approach. Case⑤ patient was suspected that the depth of tumor was muscularis propria. We judged that this clinical T2 patient had no lymph node metastasis in preoperative CT, and we were able to gain curative resection without neo-adjuvant chemotherapy. Therefore, distal gastrectomy with D2 dissection was performed. Total gastrectomy was selected for two patients with tumor located in U/Less area.Table 1Patients characteristic 1.Table 1Case no.Age/sexTumor location/macroscopic findingsprocedureLN dissection①65/FL/Less IIc 12 mmDGD1+②69/MM/Gre IIc 20 mmDGD1+③76/MU/Less IIa 20 mmTGD1+④70/MU/Less IIa 22 mmTGD1+⑤75/FL/Ant type3 12 mmDGD2⑥75/MU/Less IIc 15 mmTGD1+[^1][^2][^3][^4][^5][^6][^7]

The results of pathology and SN mapping are shown in [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}. We were able to observe the ICG positive lymphatic flow and lymph nodes in all 6 patients. Final pathological diagnosis showed all Stage I.Table 2Patients characteristic 2.Table 2Case no.PathologyLymphatic area positve for ICGNunber of LN positve for ICGSN(metastaticLN/ICG positive LN)①por sm n0(0/33)LGA, RGA,RGEA8No.3(0/3), No.4d(0/1), No.6(0/2)ly1 v0No.7(0/1), No.8a(0/1)②por m n1(1/21)LGA, RGA3No.4d(1/1), No.6(0/1), No.8a(0/1)ly0 v0③tub2 sm n0(0/32)LGA8No.2(0/2), No.3(0/3), No.7(0/3)ly1 v0④muc sm n0(0/42)LGA, LGEA16No.1(0/2), No.2(0/2), No.3(0/11)ly2 v2No.4sb(0/1)⑤tub1 sm n0(0/45)LGA, RGA, RGEA8No.1(0/1), No.3(0/5), No.6(0/1)ly0 v0No.8a(0/1)⑥tub1 m n0(0/45)LGA1No.1(0/1)ly0 v0[^8][^9][^10][^11][^12][^13][^14][^15][^16][^17]Table 3Results of SN biopsy and diagnostic Accuracy.Table 3VariableNo.%SN identification Detected6100 Undetected00No. of identified SNs Mean ± SD7.0 ± 4.7pN factor6 pN positive117 pN negative583SN metastasis1 pSN positive1100 pSN negative (false negative)00

All the patients had ICG positive lymphatic area in left gastric artery (LGA) area.

Two patients with tumor located in L area had ICG positive flow to right gastroepipoloic artery (RGEA) area.

The mean of ICG positive lymph nodes was 7.0 ± 4.7. Case② patient had a metastatic lymph node in station No.4. This node was positive for ICG.

All patients had curative resection. The median of postoperative follow up was 13 months (range 11--14). Although observation after surgey is short, there are no recurrence and metastasis.

4. Discussion {#sec4}
=============

Several successful studies for SN mapping in gastric cancer have been reported.

Miwa et al. reported SN mapping in gastric cancer using patent blue [@bib5]. Isozaki et al. evaluated SN identification with isosulfan blue. SN mapping using dye is easy and simple methods [@bib13].

Some surgeons use ICG fluorescence-guided method for SN mapping. Nimura et al. reported the method combined with infrared ray electronic endoscopy (IREE) (Olympus Optical, Tokyo, Japan) [@bib8]. Kinami et al. applied the Photodynamic Eye (PDE) (Hamamatsu Photonics Co., Ltd., Hamamatsu, Shizuoka, Japan) to detect ICG fluorescence [@bib14].

ICG fluorescence-guided methods had a critical problem. The original detection systems for ICG fluorescence have gray scale imaging and require a dark room. The operation can be interrupted during the observation of the fluorescence.

In cooperation with Sato\'s (Kochi Medical School) development of hypereye charge-coupled device camera system: HyperEye Medical System (HEMS; Mizuho Corporation, Tokyo, Japan), Yoshida et al. applied it to sentinel node mapping in the early gastric cancer patients. HEMS can simultaneously detect color and near-infrared rays and can be used under bright light [@bib15], [@bib16]. The operation can be continued, simultaneously under the guidance of ICG fluorescence.

However, method with the HEMS have demerits. Recent laparoscopic surgery for gastric cancer have tendency that mini-laparotomy for removing the specimen is placed at the umbilicus and incision size become smaller. We considered that camera heads of HEMS may not be suitable for SN mapping and navigation with laparoscopy in the future.

To overcome demerits of these methods, we applied PINPOINT^®^ for gastric cancer surgery to identify lymphatic flows and SNs. Jafari et al. performed intraoperative assessment of anastomotic perfusion in laparoscopic left-Sided/anterior resection for colorectal disease with PINPOINT [@bib11]. Sherwinter et al. showed a video of a laparoscopic cholecystectomy performed under NIR cholangiographic guidance and highlights its ability to identify anomalous anatomy [@bib17].

The system includes a surgical laparoscope and camera head optimized for visible and near infrared illumination and imaging, and is designed to be connected to a medical grade-high definition color video monitor and all components may be mounted on a stand-alone endoscopy tower [@bib18].

The PINPOINT system allows simultaneous display of multiple images, including standard high definition white light image, SPY image and Colorized image. As figures, clear view and image were obtained [@bib17]. Main lesion and SNs were identified in all cases. Case1 and 6 had preoperative endoscopic submucosal dissection (ESD).

The results of our methods was similar to what previous paper reported [@bib9], [@bib19], [@bib20]. The detection rate of ICG fluorescence imaging was 100.0%. ICG positive lymphatic area existed in left gastric artery (LGA) area in all the patients. Two patients with tumor located in L area had ICG positive flow to right gastroepipoloic artery (RGEA) area.

It is the key findings that metastatic lymph node in Case 2 was positive for ICG. The number of ICG positive node and existence of metastatic LN within the direction of ICG flow is important for SN related surgery. Our findings in [Table 2](#tbl2){ref-type="table"} reflects this concept. Decreasing false negative (metastatic LN with non--ICG positive) is the key for the SN navigation. Kitagawa et al. reported 1% of false negative [@bib9]. We believe that our method with clear images has the possibility for improvement of detection including sentinel and metastatic LN.

Limitation of this method is optimal concentration of ICG and timing for tracer injection. There is no reports describing the ICG concentration with PINPOINT^®^ because of new device. We should think differently from all other SN methods with ICG. We performing the injection the day before surgery according to Kitagawa\'s dual tracer method and Kinami\'s ICG method [@bib4], [@bib14]. Only just 6 cases, SNs were all identified and mean SNs was 8.6. Accumulating further cases, now we are examining whether 33.3 μg/ml of ICG is adequate concentration for injection and optimal count of SNs or not.

In conclusion, our method with ICG and PINPOINT^®^ made identification of ICG positive lymph nodes easy in SN mapping in back-table under room light. Although further accumulation and analysis are necessary, we may be able to apply this method for avoiding unnecessary D2 dissection, intraoperative SN mapping and modified resection of laparoscopic gastric cancer surgey [@bib21], [@bib22], [@bib23], [@bib24].
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[^1]: U: upper third.

[^2]: M: middle third.

[^3]: L: lower third.

[^4]: Less: lesser lesser curvature.

[^5]: Gre: greater curvatures.

[^6]: DG: distal gastrectomy.

[^7]: TG: total gastrectomy.

[^8]: por: poorly differentiated adenocarcinoma.

[^9]: muc: mucinous adenocarcinoma.

[^10]: tub1: well differentiated adenocarcinoma.

[^11]: tub2: moderately differentiated adenocarcinoma.

[^12]: m: mucosa.

[^13]: sm: submucosa.

[^14]: LGA: left gastric artery.

[^15]: LGEA: left gastroepiploic artery.

[^16]: RGA: right gastric artery.

[^17]: RGEA: right gastroepiploic artery.
